Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients

References

1. • Cascella NG
   • Macciardi F
   • Cavallini C
   • Smeraldi E
   D-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia—An open-label study.
   J Neural Transm Gen Sect. 1994; 95: 105-111
   • Google Scholar
2. • Goff DC
   • Tsai GC
   • Manoach DS
   • Coyle JT
   Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
   Am J Psychiatry. 1995; 152: 1213-1215
   • Google Scholar
3. • Itil T
   • Keskiner A
   • Kiremitci N
   • Holden JM
   Effect of phencyclidine in chronic schizophrenics.
   Can Psychiatr Assoc J. 1967; 12: 209-212
   • Google Scholar
4. • Javitt DC
   • Zukin SR
   Recent advances in the phencyclidine model of schizophrenia.
   Am J Psychiatry. 1991; 148 ([see comments]): 1301-1308
   • Google Scholar
5. • Javitt DC
   • Zylberman I
   • Zukin SR
   • Heresco-Levy U
   • Lindenmayer J
   Amelioration of negative symptoms in schizophrenia by glycine.
   Am J Psychiatry. 1994; 151: 1234-1236
   • Google Scholar
6. • Kay SR
   • Fiszbein A
   • Opler LA
   The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
   Schizophr Bull. 1987; 13: 261-276
   • Google Scholar
7. • Krystal JH
   • Karper LP
   • Seibyl JP
   • et al.
   Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans.
   Arch Gen Psychiatry. 1994; 51: 199-214
   • Google Scholar
8. • Lahti AC
   • Koffel B
   • Laporte D
   • Tamminga CA
   Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
   Neuropsychopharmacology. 1995; 13: 9-19
   • Google Scholar
9. • Luby ED
   • Cohen BD
   • Rosenbaum G
   • Gottlieb JS
   • Kelly R
   Study of a new schizophrenomimetic drug—Sernyl.
   AMA Arch Neurol Psychiatry. 1959; 81: 363-369
   • Google Scholar
10. • Mandell GL
    • Petri WAJ
    Drugs used in the chemotherapy of tubercuclosis, Mycobacterium avium complex disease, and leprosy.
    in: Goodmann LS Gillmann A The Pharmacological Basis of Therapeutics. McGraw-Hill, Philadelphia1996: 1164-1165
    • Google Scholar
11. • Olney JW
    • Farber NB
    Glutamate receptor dysfunction and schizophrenia.
    Arch Gen Psychiatry. 1995; 52: 998-1007
    • Google Scholar
12. • Thompson LT
    • Moskal JR
    • Disterhoft JF
    Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine.
    Nature. 1992; 359: 638-641
    • Google Scholar